Article ID Journal Published Year Pages File Type
2529763 Current Opinion in Pharmacology 2016 7 Pages PDF
Abstract

•Neuroinflammation is a key risk factor in neurodegenerative diseases.•Mac1 signaling bridges chronic neuroinflammation and progressive neuronal loss.•NADPH oxidase could be a novel therapeutic target for neurodegenerative diseases.

As average life expectancy rises throughout the world, neurodegenerative diseases have emerged as one of the greatest global public heath challenges in modern times. Substantial efforts have been made in researching neurodegenerative diseases over the last few decades, yet their predominantly sporadic nature has made uncovering their etiologies challenging. Mounting evidence has suggested that factors like damage-associated molecular patterns (DAMPs) released by stressed and dying neurons are likely involved in disease pathology and in stimulating chronic activation of microglia that contributes to neuronal oxidative stress and degeneration. This review focuses on how the microglial integrin receptor Mac1 and its downstream effector NADPH oxidase (NOX2) contribute to maintaining chronic neuroinflammation and are crucial in inflammation-driven neurotoxicity in neurodegenerative diseases. Our hope is to provide new insights on novel targets and therapies that could slow or even halt neurodegeneration.

Related Topics
Life Sciences Neuroscience Cellular and Molecular Neuroscience
Authors
, , ,